| 000 | 01637 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250518022652.0 | ||
| 264 | 0 | _c20190429 | |
| 008 | 201904s 0 0 eng d | ||
| 022 | _a1643-3750 | ||
| 024 | 7 |
_a10.12659/MSM.914340 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMing, Yingzi | |
| 245 | 0 | 0 |
_aAnti-Diabetogenic Properties of Mineralocorticoid Receptor Antagonists: Implications for Enhanced Safety and Efficacy of Post-Transplantation Pharmacotherapies. _h[electronic resource] |
| 260 |
_bMedical science monitor : international medical journal of experimental and clinical research _cFeb 2019 |
||
| 300 |
_a1102-1104 p. _bdigital |
||
| 500 | _aPublication Type: Editorial | ||
| 650 | 0 | 4 |
_aCalcineurin _xmetabolism |
| 650 | 0 | 4 | _aCalcineurin Inhibitors |
| 650 | 0 | 4 | _aCyclosporine |
| 650 | 0 | 4 |
_aDiabetes Complications _xdrug therapy |
| 650 | 0 | 4 |
_aDiabetes Mellitus _xchemically induced |
| 650 | 0 | 4 | _aEverolimus |
| 650 | 0 | 4 |
_aGraft Rejection _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xmetabolism |
| 650 | 0 | 4 | _aKidney Transplantation |
| 650 | 0 | 4 |
_aMineralocorticoid Receptor Antagonists _xpharmacology |
| 650 | 0 | 4 | _aSirolimus |
| 650 | 0 | 4 |
_aSpironolactone _xpharmacology |
| 650 | 0 | 4 | _aTacrolimus |
| 650 | 0 | 4 |
_aTransplantation Tolerance _xphysiology |
| 700 | 1 | _aStefano, George B | |
| 700 | 1 | _aKream, Richard M | |
| 700 | 1 | _aZhuang, Quan | |
| 773 | 0 |
_tMedical science monitor : international medical journal of experimental and clinical research _gvol. 25 _gp. 1102-1104 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.12659/MSM.914340 _zAvailable from publisher's website |
| 999 |
_c29347939 _d29347939 |
||